These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. Menegola E, Di Renzo F, Broccia ML, Prudenziati M, Minucci S, Massa V, Giavini E. Birth Defects Res B Dev Reprod Toxicol; 2005 Oct 01; 74(5):392-8. PubMed ID: 16193500 [Abstract] [Full Text] [Related]
3. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects. Tung EW, Winn LM. Mol Pharmacol; 2011 Dec 01; 80(6):979-87. PubMed ID: 21868484 [Abstract] [Full Text] [Related]
4. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice. Dawson JE, Raymond AM, Winn LM. Toxicol Appl Pharmacol; 2006 Mar 01; 211(2):124-32. PubMed ID: 16112698 [Abstract] [Full Text] [Related]
5. VPA-related axial skeletal defects and apoptosis: a proposed event cascade. Di Renzo F, Broccia ML, Giavini E, Menegola E. Reprod Toxicol; 2010 Jan 01; 29(1):106-12. PubMed ID: 19850124 [Abstract] [Full Text] [Related]
6. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse. Padmanabhan R, Hameed MS. J Craniofac Genet Dev Biol; 1994 Jan 01; 14(3):192-205. PubMed ID: 7852547 [Abstract] [Full Text] [Related]
7. Valproic acid-induced DNA damage increases embryonic p27(KIP1) and caspase-3 expression: a mechanism for valproic-acid induced neural tube defects. Tung EW, Winn LM. Reprod Toxicol; 2011 Nov 01; 32(3):255-60. PubMed ID: 21708246 [Abstract] [Full Text] [Related]
10. Histone modifications at the blastocyst Axin1(Fu) locus mark the heritability of in vitro culture-induced epigenetic alterations in mice. Fernandez-Gonzalez R, Ramirez MA, Pericuesta E, Calle A, Gutierrez-Adan A. Biol Reprod; 2010 Nov 01; 83(5):720-7. PubMed ID: 20650886 [Abstract] [Full Text] [Related]
12. Myo-inositol enhances teratogenicity of valproic acid in the mouse. Massa V, Wlodarczyk B, Giavini E, Finnell RH. Birth Defects Res A Clin Mol Teratol; 2006 Mar 01; 76(3):200-4. PubMed ID: 16511884 [Abstract] [Full Text] [Related]
13. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Milutinovic S, D'Alessio AC, Detich N, Szyf M. Carcinogenesis; 2007 Mar 01; 28(3):560-71. PubMed ID: 17012225 [Abstract] [Full Text] [Related]
14. Valproic acid-induced somite teratogenesis in the chick embryo: relationship with Pax-1 gene expression. Barnes GL, Mariani BD, Tuan RS. Teratology; 1996 Aug 01; 54(2):93-102. PubMed ID: 8948545 [Abstract] [Full Text] [Related]
16. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Eikel D, Lampen A, Nau H. Chem Res Toxicol; 2006 Feb 01; 19(2):272-8. PubMed ID: 16485903 [Abstract] [Full Text] [Related]